fund FemTech Research and Innovation
Bringing out Lyv's scientific value proposition
Lyv approached Dynergie to structure and develop its research activities in order to obtain Young Innovative Company status and Research Tax Credit funding.
An approach that mobilizes health sciences and social sciences and humanities
Our role was to understand and deconstruct Lyv's activity in order to enhance the contribution of new knowledge to the advancement of science.
Because HealthTech and FemTech science is not just the domain of biologists and doctors, we have opted for a multidisciplinary approach that also includes the humanities and social sciences.
For Lyv, science is also about :
- To study and understand the daily lives of women suffering from endometriosis, in all the diversity of cases it represents.
- Ask what are the best ways to empower women in the face of this pathology.
- Or determine whether a 100% digital therapy program is effective in improving their quality of life and reducing their symptoms.
The success of this project.
JEI rescript accepted for Lyv
Lyv's JEI rescript was approved by the tax authorities in 2023, a milestone in our collaboration.
Anticipating future financing
This success paves the way for future financing projects for 2024, including public aid and bank financing.
To conclude.
With the approval of JEI status and the prospect of funding, Lyv Healthcare has established itself as a promising player in the world of FemTech, heralding a great step forward for innovation and research in this field.
Our offers
Everything you need to boost your innovation and your R&D.